COPYRIGHT© Jilin Zixin Pharmaceutical Industrial Co.,Ltd.

COPYRIGHT© 2018  吉林紫鑫药业股份有限公司

The company has won many awards in the Chinese pharmaceutical industry.

Page view

On June 20, 2017, the 2016 China Pharmaceutical Industry's Most Influential List Release Conference and 2017 China Pharmaceuticals jointly sponsored by the All-China Federation of Industry and Commerce Pharmaceutical Industry Association, Yunnan Science and Technology Department, Yunnan Provincial Federation of Industry and Commerce, and Yunnan Investment Promotion Bureau The Industrial Development Summit Forum (hereinafter referred to as the “Forum”) was held in Kunming. The forum was based on the theme of “Implementing National Strategy, Promoting Industry Cooperation, Creating Medical Brilliance”, and more than 300 pharmaceutical industries and more than 100 chain stores across the country. More than 800 people from pharmacies, entrepreneurs in the pharmaceutical industry such as R&D, circulation, and medical devices, experts and professors in the industry, and media representatives attended the forum. On behalf of the company, Zhong Yunxiang, the deputy general manager of the group, was invited to participate in this forum and returned to the company.

 

On the evening of June 20th, the most influential list of China's pharmaceutical industry in 2016 was officially released. The selection committee consisting of the expert committee of the conference, relevant personnel of the regulatory department and member units adheres to the principles of openness, objectivity and fairness and selects the best enterprises and individuals. Zixin Pharmaceutical won three awards in the “2016 Top 50 Enterprises in China's Pharmaceutical Industry Growth”, “2016 Top Ten Standardized Planting Bases for Quality Chinese Medicines” and “2016 Top Ten Group Gold Buyers in the Pharmaceutical Industry”. It is the best award for the company that has been adhering to the core values ​​of “Pin Shuren, Dezhi Medicine” for many years and adheres to the business philosophy of “Qi Zhen Chun Chun”.

 

The release of the most influential list of the pharmaceutical industry aims to encourage excellence, set benchmarks, play role models and promote industry development. At the same time, the activities integrated the high-end resources of the government, production, learning, research, media and capital, and built a platform for industry exchange, resource docking, cross-border communication and exploration opportunities.

 

The company will take this award as an opportunity to fully integrate and utilize industry resources, develop and innovate, and strive to strengthen the proprietary Chinese medicine industry chain, realize the big healthy ecological pattern with “scientific and technological innovation” as its core competitiveness, and promote the sustainable development of China's traditional Chinese medicine industry. healthy growth.